New insights into the structural basis of integrin activation

Blood

Volumn 102, Issue 4, 2003, Pages 1155-1159

  Xiong, Jian Ping ^b   Stehle, Thilo ^b   Goodman, Simon L ^b   Arnaout, M Amin ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BETA3 INTEGRIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; MANGANESE;

CELL ADHESION; CELL FUNCTION; CELL MEMBRANE; CELL STRUCTURE; CELL SURFACE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ELECTRON MICROSCOPY; EXTRACELLULAR SPACE; HUMAN; HYPOTHESIS; INTRACELLULAR SPACE; LIGAND BINDING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 0042739086     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0334     Document Type: Review

References (59)

1. Nermut MV, Green NM, Eason P, Yamada SS, Yamada KM. Electron microscopy and structural model of human fibronectin receptor. EMBO J. 1988;7:4093-4099.
2. Erb EM, Tangemann K, Bohrmann B, Muller B, Engel J. Integrin alphaIIb beta3 reconstituted into lipid bilayers is nonclustered in its activated state but clusters after fibrinogen binding. Biochemistry. 1997;36:7395-7402.
3. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 1992;69:11-26.
4. Hughes PE, Diaz-Gonzalez F, Leong L, et al. Breaking the integrin binge. J Biol Chem. 1996;271:6571-6574.
5. Arnaout MA. Integrin structure: new twists and turns in dynamic cell adhesion. Immunol Rev. 2002;186:125-140.
6. Garcia AJ, Takagi J, Boettiger D. Two-stage activation for alpha5beta1 integrin binding to surface-adsorbed fibronectin. J Biol Chem. 1998;273:34710-34715.
7. Cai TQ, Wright SD. Energetics of leukocyte integrin activation. J Biol Chem. 1995;270:14358-14365.
8. Hantgan RR, Paumi C, Rocco M, Weisel JW. Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on alphaIIbbeta3 integrin conformation and oligomerization. Biochemistry. 1999;38:14461-14474.
9. Cai TQ, Law SK, Zhao HR, Wright SD. Reversible inactivation of purified leukocyte integrin CR3 (CD11b/CD18, alpham beta2) by removal of divalent cations from a cryptic site. Cell Adhes Commun. 1995;3:399-406.
10. Hato T, Pampori N, Shattil SJ. Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin alphaIIb beta3. J Cell Biol. 1998;141:1685-1695.
11. Constantin G, Majeed M, Giagulli C, et al. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity. 2000;13:759-769.
12. Du X, Plow EF, Frelinger AL, O'Toole TE, Loftus JC, Ginsberg MH. Ligands "activate" integrin αIIbβ3 (platelet GPIlb-IIIa). Cell. 1991;65:409-416.
13. Mazurov AV, Khaspekova SG, Byzova TV, et al. Stimulation of platelet glycoprotein IIb-IIIa (alphaIIb beta3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa. FEBS Lett. 1996;391:84-88.
14. Smith JW, Piotrowicz RS, Mathis D. A mechanism for divalent cation regulation of beta3-integrins. J Biol Chem. 1994;269:960-967.
15. Du X, Gu M, Weisel JW, et al. Long range propagation of conformational changes in integrin alphaIIb beta3. J Biol Chem. 1993;268:23087-23092.
16. Xiong JP, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin alphaV beta3. Science. 2001;294:339-345.
17. Liddington RC, Ginsberg MH. Integrin activation takes shape. J Cell Biol. 2002;158:833-839.
18. Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extra-cellular domains in outside-in and inside-out signaling. Cell. 2002;110:599-511.
19. Michishita M, Videm V, Arnaout MA. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell. 1993;72:857-867.
20. Lee J-O, Rieu P, Arnaout MA, Liddington R. Crystal Structure of the A-domain from the α-subunit of β2 integrin complement receptor type 3 (CR3, CD11b/CD18). Cell. 1995;80:631-638.
21. Lee J-O, Anne-Bankston L, Arnaout MA, Liddington RC. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure. 1995;3:1333-1340.
22. Beglova N, Blacklow SC, Takagi J, Springer TA. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol. 2002;9:282-287.
23. Takagi J, Erickson HP, Springer TA. C-terminal opening mimics 'inside-out' activation of integrin alpha5beta1. Nat Struct Biol. 2001;8:412-416.
24. Xiong JP, Stehle T, Zhang R, et al. Crystal structure of the extracellular segment of integrin alphaV beta3 in complex with an Arg-Gly-Asp ligand. Science. 2002;296:151-155.
25. Chen LL, Whitty A, Scott D, et al. Evidence that ligand and metal ion binding to integrin alpha4 beta1 are regulated through a coupled equilibrium. J Biol Chem. 2001;276:36520-36529.
26. Wall MA, Coleman DE, Lee E, et al. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell. 1995;83:1047-1058.
27. Legler DF, Wiedle G, Ross FP, Imhof BA. Super-activation of integrin alphavbeta3 by low antagonist concentrations. J Cell Sci. 2001;114:1545-1553.
28. Tsuchida J, Ueki S, Takada Y, Saito Y, Takagi J. The 'ligand-induced conformational change' of alpha 5 beta 1 integrin. Relocation of alpha5 subunit to uncover the beta1 stalk region. J Cell Sci. 1998;111(pt 12):f759-1766.
29. Pelletier AJ, Kunicki T, Ruggeri ZM, Quaranta V. The activation state of the integrin alpha IIb beta 3 affects outside-in signals leading to cell spreading and focal adhesion kinase phosphorylation. J Biol Chem. 1995;270:18133-18140.
30. Andrieux A, Rabiet MJ, Chapel A, Concord E, Marguerie G. A highly conserved sequence of the Arg-Gly-Asp-binding domain of the integrin beta3 subunit is sensitive to stimulation. J Biol Chem. 1991;266:14202-14207.
31. Kouns WC, Steiner B, Kunicki TJ, et al. Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood. 1994;84:1108-1115.
32. Calvete JJ. On the structure and function of platelet integrin alphaIIb beta3, the fibrinogen receptor. Proc Soc Exp Biol Med. 1995;208:346-360.
33. Lu C, Shimaoka M, Zang Q, Takagi J, Springer TA. Locking in alternate conformations of the integrin alphaL beta2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci U S A. 2001;98:2393-2398.
34. Mould AP, Askari JA, Barton S, et al. Integrin activation involves a conformational change in the alpha 1 helix of the beta subunit A-domain. J Biol Chem. 2002;277:19800-19805.
35. Yan B, Hu DD, Knowles SK, Smith JW. Probing chemical and conformational differences in the resting and active conformers of platelet integrin alphaIIb beta3. J Biol Chem. 2000;275:7249-7260.
36. Sims PJ, Ginsberg MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem. 1991;266:7345-7352.
37. Valentin N, Visentin GP, Newman PJ. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PIA 1: evidence for heterogeneity in the humoral response. Blood. 1995;85:3028-3033.
38. Adair BD, Yeager M. Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-ray crystallography. Proc Natl Acad Sci U S A. 2002;99:14059-14064.
39. Calzada MJ, Alvarez MV, Gonzalez-Rodriguez J. Agonist-specific structural rearrangements of integrin alpha IIbbeta 3. Confirmation of the bent conformation in platelets at rest and after activation. J Biol Chem. 2002;277:39899-39908.
40. Cierniewski CS, Byzova T, Papierak M, et al. Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses. J Biol Chem. 1999;274:16923-16932.
41. Huth JR, Olejniczak ET, Mendoza R, et al. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A. 2000;97:5231-5236.
42. Xiong JP, Li R, Essafi M, Stehle T, Arnaout MA. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem. 2000;275:38762-38767.
43. Kallen J, Welzenbach K, Ramage P, et al. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11 a I-domain. J Mol Biol. 1999;292:1-9.
44. Vinogradova O, Velyvis A, Velyviene A, et al. A structural mechanism of integrin alphaIIb beta3 "inside-out" activation as regulated by its cytoplasmic face. Cell. 2002;110:587-597.
45. Armulik A, Nilsson I, von Heijne G, Johansson S. Determination of the border between the transmembrane and cytoplasmic domains of human integrin subunits. J Biol Chem. 1999;274:37030-37034.
46. Gottschalk KE, Adams PD, Brunger AT, Kessler H. Transmembrane signal transduction of the alpha (IIb)beta(3) integrin. Protein Sci. 2002;11:1800-1812.
47. Humphries MJ. Integrin structure. Biochem Soc Trans. 2000;28:311-339.
48. Wilkins JA, Li A, Ni H, Stupack DG, Shen C. Control of beta1 integrin function. Localization of stimulatory epitopes. J Biol Chem. 1996;271:3046-3051.
49. Luque A, Gomez M, Puzon W, Takada Y, Sanchez-Madrid F, Cabanas C. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J Biol Chem. 1996;271:11067-11075.
50. Puzon-McLaughlin W, Takada Y. Critical residues for ligand binding in an I domain-like structure of the integrin b1 subunit. J Biol Chem. 1996;271:20438-20443.
51. Huang C, Zang Q, Takagi J, Springer TA. Structural and functional studies with antibodies to the integrin beta2 subunit. A model for the I-like domain. J Biol Chem. 2000;275:21514-21524.
52. Kashiwagi H, Tomiyama Y, Tadokoro S, et al. A mutation in the extracellular cysteine-rich repeat region of the beta3 subunit activates integrins alphaIIb beta3 and alphaV beta3. Blood. 1999;93:2559-2568.
53. Ambo H, Kamata T, Handa M, et al. Three novel integrin beta3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients. Biochem Biophys Res Commun. 1998;251:763-768.
54. Chen P, Melchior C, Brons NH, Schlegel N, Caen J, Kieffer N. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation. J Biol Chem. 2001;276:38628-38635.
55. Humphries JD, Askari JA, Zhang XP, Takada Y, Humphries MJ, Mould AP. Molecular basis of ligand recognition by integrin alpha5 beta1, II: specificity of Arg-Gly-Asp binding is determined by Trp 157 of the alpha subunit. J Biol Chem. 2000;275:20337-20345.
56. Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Assignment of disulphide bonds in human platelet GPIIIa: a disulphide pattern for the b-subunits of the integrin family. Biochem J. 1991;274:63-71.
57. Loftus JC, Plow EF, Frelinger AL 3rd, et al. Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci U S A. 1987;84:7114-7118.
58. Arnaout MA, Goodman SL, Xiong JP. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol. 2002;14:641-651.
59. Lu G. TOP: a new method for protein structure comparisons and similarity searches. J Appl. Cryst. 2000;33:176-183.